发明名称 NALTREXONE LONG ACTING FORMULATION AND METHOD OF USE
摘要 <P>PROBLEM TO BE SOLVED: To provide an improved naltrexone therapy. <P>SOLUTION: A method for treating an individual in need of naltrexone comprising a step of parenterally administering a long acting formulation comprising naltrexone to the individual wherein the serum AUC of naltrexone is at least about two times, preferably at least about three times, more preferably about 3.3 times greater than that achieved by 50 mg/day oral administration. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011225600(A) 申请公布日期 2011.11.10
申请号 JP20110156813 申请日期 2011.07.15
申请人 ALKERMES INC 发明人 EHRICH ELLIOT
分类号 A61K31/485;A01N25/00;A61F2/00;A61K9/00;A61K9/10;A61K9/14;A61K9/50;A61K31/44;A61K47/34;A61P25/32 主分类号 A61K31/485
代理机构 代理人
主权项
地址